Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 108799295 | 10879929 | 5 | F | 20140611 | 20160902 | 20150302 | 20160907 | PER | US-PFIZER INC-2015069594 | PFIZER | 76.00 | YR | F | Y | 0.00000 | 20160907 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 108799295 | 10879929 | 1 | PS | LYRICA | PREGABALIN | 1 | 75 MG, 3X/DAY | L05022 | 21446 | 75 | MG | CAPSULE, HARD | TID | ||||||
| 108799295 | 10879929 | 2 | SS | LYRICA | PREGABALIN | 1 | 75 MG, 3X/DAY | 21446 | 75 | MG | CAPSULE, HARD | TID | |||||||
| 108799295 | 10879929 | 3 | SS | LYRICA | PREGABALIN | 1 | 75 MG, 4X/DAY | 21446 | 75 | MG | CAPSULE, HARD | QID | |||||||
| 108799295 | 10879929 | 4 | C | MECLIZINE HCL | MECLIZINE HYDROCHLORIDE | 1 | 25 MG, 3X/DAY AS NEEDED | 0 | 25 | MG | TABLET | ||||||||
| 108799295 | 10879929 | 5 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 20 MG, 2X/DAY | 0 | 20 | MG | BID | ||||||||
| 108799295 | 10879929 | 6 | C | CALCIUM VITAMIN D | CALCIUMVITAMIN D | 1 | UNK | 0 | TABLET | ||||||||||
| 108799295 | 10879929 | 7 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | UNK | 0 | TABLET | ||||||||||
| 108799295 | 10879929 | 8 | C | PRAVASTATIN SODIUM. | PRAVASTATIN SODIUM | 1 | Oral | 40 MG, 1X/DAY (AT BEDTIME) | 0 | 40 | MG | TABLET | QD | ||||||
| 108799295 | 10879929 | 9 | C | ASPIRIN 81 | ASPIRIN | 1 | 81 MG, UNK | 0 | 81 | MG | TABLET | ||||||||
| 108799295 | 10879929 | 10 | C | LOSARTAN POTASSIUM. | LOSARTAN POTASSIUM | 1 | Oral | 100 MG, DAILY | 0 | 100 | MG | TABLET | |||||||
| 108799295 | 10879929 | 11 | C | FLUOXETINE HCL | FLUOXETINE HYDROCHLORIDE | 1 | Oral | 10 MG, 1X/DAY | 0 | 10 | MG | CAPSULE | QD | ||||||
| 108799295 | 10879929 | 12 | C | GABAPENTIN. | GABAPENTIN | 1 | 200MG IN THE AM AND 200MG AT NOON AND 300 MG QHS | 0 | CAPSULE | ||||||||||
| 108799295 | 10879929 | 13 | C | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | Oral | 1 DF, DAILY | 0 | 1 | DF | CAPSULE | |||||||
| 108799295 | 10879929 | 14 | C | OXYCODONE AND ACETAMINOPHEN | ACETAMINOPHENOXYCODONE HYDROCHLORIDE | 1 | Oral | 1 DF, EVERY 4 HRS, AS NEEDED, (OXYCODONE 5 MG+ ACETAMINOPHEN 325 MG) | 0 | 1 | DF | TABLET | |||||||
| 108799295 | 10879929 | 15 | C | VALIUM | DIAZEPAM | 1 | 5 MG, 1X/DAY (TAKE ONCE EACH NIGHT BEFORE BED) | 0 | 5 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 108799295 | 10879929 | 1 | Burning sensation |
| 108799295 | 10879929 | 2 | Pain |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 108799295 | 10879929 | Fall |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 108799295 | 10879929 | 1 | 20140113 | 0 | ||
| 108799295 | 10879929 | 8 | 20111216 | 0 | ||
| 108799295 | 10879929 | 10 | 20110916 | 0 | ||
| 108799295 | 10879929 | 11 | 20111216 | 0 | ||
| 108799295 | 10879929 | 12 | 20150528 | 0 | ||
| 108799295 | 10879929 | 13 | 20120515 | 0 | ||
| 108799295 | 10879929 | 15 | 20130705 | 0 |